Can inhalations of hyaluronidase be used in acute respiratory distress-syndrome in patients with COVID-19?
https://doi.org/10.37489/2588-0519-2020-S4-32-34
Abstract
Hyaluronidase is currently not included into Russian or foreign guidelines on the treatment of acute respiratory distress-syndrome in patients with COVID-19, and such treatment is not supported by evidence of clinical effectiveness. Hyaluronidase can only be used for COVID-19 within clinical trials.
About the Authors
Yu. Yu. Kiselev
Oslo Metropolitan University
Norway
Norway
Kiselev Yuri Yu. – PhD, Associate Professor at the Faculty of Health Sciences OsloMet
Oslo
K. B. Mirzaev
Russian Medical Academy of Continuing Professional Education of the Ministry of Health of Russia
Russian Federation
Russian Federation
Mirzaev Karin B. – Candidate of Medical Sciences, Associate Professor of the Department of Clinical Pharmacology and Therapy. SPIN code: 8308-7599
Moscow
D. A. Sychev
Russian Medical Academy of Continuing Professional Education of the Ministry of Health of Russia
Russian Federation
Russian Federation
Sychev Dmitry A. – Doctor of Medical Sciences, Professor, Corresponding Member RAS, Rector, Head Department of Clinical Pharmacology and Therapy. SPIN code: 4525-7556
Moscow
References
1. Государственный реестр лекарственных средств. ЛСР-007075_08
2. https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021716lbl.pdf
3. https://www.medicines.org.uk/emc/product/1505/smpc#INDICATIONS
4. Oh BL, Jung C, Park KH, Hong YJ, Woo SJ. Therapeutic Intra-arterial Hyaluronidase Infusion for Ophthalmic Artery Occlusion Following Cosmetic Facial Filler (Hyaluronic Acid) Injection. Neuro-Ophthalmology. 2014;38(1):39—43. Published 2014 Jan 28. DOI: 10.3109/01658107.2013.830134
5. Juul SE, Kinsella MG, Truog WE, Gibson RL, Redding GJ. Lung hyaluronan decreases during group B streptococcal pneumonia in neonatal piglets. Am J Respir Crit Care Med. 1996;153(5):1567—1570. DOI: 10.1164/ajrccm.153.5.8630603
6. Uchakina ON, Castillejo CM, Bridges CC, McKallip RJ. The role of hyaluronic acid in SEB-induced acute lung inflammation. Clin Immunol. 2013;146(1):56—69. DOI: 10.1016/j.clim.2012.11.002
7. www.clinicaltrials.gov
8. https://grls.rosminzdrav.ru/CiPermitionReg.aspx
9. Shi Y, Wang Y, Shao C et al. COVID-19 infection: the perspectives on immune responses. Cell Death Differ. 2020 May;27(5):1451-1454. DOI: 10.1038/s41418-020-0530-3
10. Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020 Apr;8(4):420-422. DOI: 10.1016/S22132600(20)30076-X
11. Hallgren R, Samuelsson T, Laurent TC, Modig J. Accumulation of hyaluronan (hyaluronic acid) in the lung in adult respiratory distress syndrome. Am Rev Respir Dis. 1989 Mar;139(3):682-7. DOI: 10.1164/ajrccm/139.3.682
12. Bell TJ, Brand OJ, Morgan DJ et al. Defective lung function following influenza virus is due to prolonged, reversible hyaluronan synthesis. Matrix Biol. 2019 Jul;80:14-28. DOI: 10.1016/j.matbio.2018.06.006
13. https://www.ficm.ac.uk/sites/default/files/ficm_ics_ards_guideline_-_july_2018.pdf
14. Griffiths MJD, McAuley DF, Perkins GD et al. Guidelines on the management of acute respiratory distress syndrome. BMJ Open Respir Res. 2019 May 24;6(1):e000420. DOI: 10.1136/bmjresp-2019-000420
15. Clinical guidelines «Diagnosis and intensive therapy of acute respiratory distress syndrome». (In Russ). http://far.org.ru/recomendation
16. https://static-1.rosminzdrav.ru/system/attachments/attaches/000/050/122/original/28042020_%D0%9CR_COVID-19_v6.pdf
Review
For citations:
Kiselev Yu.Yu., Mirzaev K.B., Sychev D.A. Can inhalations of hyaluronidase be used in acute respiratory distress-syndrome in patients with COVID-19? Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice. 2020;(4S):32-34. (In Russ.) https://doi.org/10.37489/2588-0519-2020-S4-32-34
Views:
1396
Email this article 